Is it Possible to Screen for Type 2 Diabetes at Day 2 in Gestational Diabetes Mellitus Patients Postpartum?

Type 2 Diabetes Clinical Trial

— DG4  

Official title:

Is it Possible to Screen for Type 2 Diabetes at Day 2 Gestational Diabetes Mellitus Postpartum?

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00921882
• Other study ID #: 07-084
• Status: Completed
• Start date: June 2008
• Est. completion date: May 2013

Study information

• Verified date: May 2018
• Source: Université de Sherbrooke
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Within 6 months of delivery, women who had gestational diabetes mellitus should be screened for type 2 diabetes with a fasting plasma glucose test and/or a 2-h postchallenge glycemia in a 75-g oral glucose tolerance test. However, not all women are screened. The objective of this study is to compare the screening test for type 2 diabetes done at 48 hours post-partum versus 8 weeks post-partum. The investigators want to measure the specificity, sensitivity, false and true predictive values of the screening test at 48 hours post-partum compared to the gold-standard.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 51
• Est. completion date: May 2013
• Est. primary completion date: October 2012
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• Dx of gestational diabetes treated with insulin

• To be in post-partum

• Delivery of a baby of at least 37 weeks of gestation

• Have signed the consent form

Exclusion Criteria:

• History of glucose intolerance of diabetes before the pregnancy

• Obstetrical pathology during pregnancy

Related Conditions & MeSH terms

• Diabetes Mellitus
• Diabetes Mellitus, Type 2
• Diabetes, Gestational
• Gestational Diabetes Mellitus
• Type 2 Diabetes

Intervention

Procedure:
• Oral glucose tolerance test
Subjects will have the Oral glucose tolerance test 48 hours post-partum and the same test 8 weeks post-partum.

Locations

Country	Name	City	State
Canada	Centre hospitalier universitaire de Sherbrooke	Sherbrooke	Quebec

Sponsors (1)

Lead Sponsor	Collaborator
Université de Sherbrooke

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Oral glucose tolerance test	Sensitivity, specificity, true and false predictive values of the oral glucose tolerance test	8 weeks post partum
Secondary	Acceptability of screening test	Prefered moment to do the screening test (48 hours post partum or 8 weeks post partum)	8 weeks post partum